|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
2 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling, general and administrative expense | |||||
| Amortization expense | |||||
| Founders advisory fees - related party | |||||
| Intangible impairment | |||||
| Other operating expense | |||||
| Total operating expenses | |||||
| Operating (loss) income | |||||
| Other expense (income): | |||||
| Interest expense, net | |||||
| Gain on contingent earn-out | |||||
| Foreign currency (gain) loss | |||||
| Other (income) expense, net | |||||
| Total other expense, net | |||||
| (Loss) income before income taxes | |||||
| Income tax benefit | |||||
| Net (loss) income | |||||
| Other comprehensive income (loss), net of tax: | |||||
| Foreign currency translation adjustments | |||||
| Total comprehensive (loss) income | |||||
| (Loss) earnings per share: | |||||
| Basic (in usd per share) | |||||
| Diluted (in usd per share) | |||||
| Weighted average number of shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...